anaboliclondon.com
No products in the cart.
Return To Shopanaboliclondon.com
No products in the cart.
Return To ShopMestinon Meda Pharma, containing the active ingredient pyridostigmine bromide, is a drug primarily used in the management of myasthenia gravis, an autoimmune disorder that affects neuromuscular transmission. In the realm of sports pharmacology, Mestinon is sometimes considered for its potential benefits in enhancing muscle function and endurance. The mechanism of action involves inhibition of the enzyme acetylcholinesterase, which breaks down the neurotransmitter acetylcholine. By preventing the degradation of acetylcholine, Mestinon increases its availability at the neuromuscular junction, potentially leading to improved muscle contraction and endurance during physical activities. This property has garnered interest among athletes looking to enhance their performance.
The potential benefits of Mestinon for athletes include enhanced endurance, increased muscle mass, and improved recovery times following intense exercise. Endurance athletes, in particular, may benefit from the drug’s ability to promote sustained muscle contraction and delay fatigue. By increasing neuromuscular transmission efficiency, athletes can potentially train harder and for longer periods. Enhanced muscle mass can also be a consequence of more effective strength training sessions, as improved neuromuscular coordination allows for better muscle engagement.
Recovery is another critical area where Mestinon may show promise. Faster recovery times can lead to reduced downtime between training sessions, enabling athletes to maintain a more rigorous training regimen. This can be particularly advantageous in sports that require high levels of stamina and quick recovery between events. However, it’s essential to approach the use of such substances cautiously, as the effects can vary widely among individuals and depend on numerous factors including dosage and overall health.
In Great Britain, acquiring Mestinon Meda Pharma legally necessitates a prescription from a qualified healthcare professional. The drug is classified as a prescription medication, primarily because of its effects on the nervous system and potential side effects. Athletes interested in using Mestinon should consult with their physicians to discuss their individual situations and medical histories. Once a prescription is obtained, Mestinon can be sourced from licensed pharmacies, either through physical locations or reputable online pharmacies that follow national regulations for drug sale and distribution.
For those considering online purchases, it is imperative to choose platforms that require prescriptions and are registered with health authorities to ensure authenticity and safety of the medication. Ordering from unauthorized sources can pose significant risks regarding the quality and efficacy of the drugs obtained.
Before using Mestinon Meda Pharma, athletes should seek a thorough medical consultation. A healthcare professional can provide valuable guidance regarding the appropriateness of the drug based on individual health conditions, existing medications, and potential for adverse reactions. Some individuals may experience side effects such as gastrointestinal disturbances, increased salivation, or muscle cramps, which can be short-lived or more severe depending on the dosage and individual response.
Key safety tips include:
For athletes using Mestinon Meda Pharma, combining it with appropriate dietary supplements may enhance overall performance and recovery. However, caution is advised, as certain supplements can interact negatively with medications. Common complementary supplements include:
1. Protein powders: Aids in muscle repair and growth.
2. Creatine: May enhance strength and power output.
3. Branched-chain amino acids (BCAAs): Supports muscle recovery and reduces fatigue.
4. Omega-3 fatty acids: Helps reduce inflammation and promotes recovery.
Prior to integrating any supplement with Mestinon, athletes should consult their healthcare provider to ensure compatibility and effectively tailor their supplementation strategy. This will help achieve the desired athletic outcomes while minimizing health risks.
| Active substance | Pyridostigmine Bromide |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Monitoring of cholinesterase levels may be conducted to assess efficacy and dosage requirements |
| Also known as | Mestinon, Regonol |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause fluctuations, typically lowering blood pressure due to vasodilation |
| Trade name | Mestinon, Regonol |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 3-hydroxy-1-methylpyridinium bromide dimethylcarbamate |
| Formula | C9H13BrN2O2 |
| Substance class | Acetylcholinesterase inhibitor |
| Main action | Inhibits the breakdown of acetylcholine, thereby increasing its concentration at neuromuscular junctions |
| Half-life | Approximately 1.78 to 2.25 hours |
| Dosage (medical) | Typical starting dose for adults in the treatment of myasthenia gravis is 60 mg taken orally every 4 hours but can vary based on individual patient needs and conditions |
| Dosage (sports) | Not applicable as it is not legally used to enhance athletic performance |
| Effects | Improved muscle strength in patients with myasthenia gravis |
| Side effects | Nausea, vomiting, diarrhea, abdominal cramps, increased salivation and sweating, muscle cramps, and twitching |
| Use in sports | Not used or recommended |
| Manufacturer | Meda Pharma |
€96.00
Reviews
There are no reviews yet.